Quick Answer
Moleculin Biotech, Inc. reported Cash And Cash Equivalents At Carrying Value of $8.88 million for the year ending 2025.
- Moleculin Biotech, Inc. showed an increase of +107.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Moleculin Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 18, 2026.
- XBRL data for this metric is available from 2015 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $8.88 million | Fiscal year 2024: $4.28 million | Fiscal year 2023: $23.55 million | Fiscal year 2022: $43.15 million | Fiscal year 2021: $70.90 million | Fiscal year 2020: $15.17 million | Fiscal year 2019: $10.74 million | Fiscal year 2018: $7.13 million | Fiscal year 2017: $7.71 million | Fiscal year 2016: $5.01 million | Fiscal year 2015: $28.0 thousand | Fiscal year 2015: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: